PEP-1-SOD1 protects brain from ischemic insult following asphyxial cardiac arrest in rats

Resuscitation

Volumn 82, Issue 8, 2011, Pages 1081-1086

  Zhang, You En ^a   Fu, Shou Zhi ^a   Li, Xiao Quan ^a   Chen, Ping ^a   Wang, Jia Liang ^a   Che, Jun ^a   Tang, Jun Ming ^a   Chen, Shi You ^b   Wang, Jia Ning ^a  

^a HUBEI UNIVERSITY OF MEDICINE   (China)

^b UNIVERSITY OF GEORGIA   (United States)

Author keywords

Cardiac arrest; Cell penetrating peptide; Cerebral ischemia; PEP 1; SOD1

Indexed keywords

CELL PENETRATING PEPTIDE; HYBRID PROTEIN; MALONALDEHYDE; NEURON SPECIFIC ENOLASE; PROTEIN S 100; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPHYXIA; BRAIN ISCHEMIA; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PURIFICATION; HEART ARREST; HISTOPATHOLOGY; MALE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; TREATMENT OUTCOME;

ANALYSIS OF VARIANCE; ANIMALS; BRAIN ISCHEMIA; CHI-SQUARE DISTRIBUTION; CYSTEAMINE; HEART ARREST; LIPID PEROXIDATION; MALE; NERVE GROWTH FACTORS; OXIDATIVE STRESS; PEPTIDES; PHOSPHOPYRUVATE HYDRATASE; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; S100 PROTEINS; SUPEROXIDE DISMUTASE;

EID: 79960229282     PISSN: 03009572     EISSN: 18731570     Source Type: Journal    
DOI: 10.1016/j.resuscitation.2011.01.034     Document Type: Article

References (33)

1. Maier C.M., Chan P.H. Role of superoxide dismutases in oxidative damage and neurodegenerative disorders. Neuroscientist 2002, 8:323-334.
2. Chan P.H. Reactive oxygen radicals in signaling and damage in the ischemic brain. J Cereb Blood Flow Metab 2001, 21:2-14.
3. Nelson S.K., Bose S.K., Grunwald G.K., Myhill P., McCord J.M. The induction of human superoxide dismutase and catalase in vivo: a fundamentally new approach to antioxidant therapy. Free Radic Biol Med 2006, 40:341-347.
4. Wadia J.S., Dowdy S.F. Protein transduction technology. Curr Opin Biotechnol 2002, 13:52-56.
5. Morris M.C., Depollier J., Mery J., Heitz F., Divita G. A peptide carrier for the delivery of biologically active proteins into mammalian cells. Nat Biotechnol 2001, 19:1173-1176.
6. An J.J., Lee Y.P., Kim S.Y., et al. Transduction of familial amyotrophic lateral sclerosis-related mutant PEP-1-SOD proteins into neuronal cells. Mol Cells 2008, 25:55-63.
7. Dong X., Wang J.N., Huang Y.Z., Guo L.Y., Kong X. Cell-penetrating peptide PEP-1-mediated transduction of enhanced green fluorescent protein into human umbilical vein endothelial cells. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2007, 29:93-97.
8. Kim D.W., Jeong H.J., Kang H.W., et al. Transduced human PEP-1-catalase fusion protein attenuates ischemic neuronal damage. Free Radic Biol Med 2009, 47:941-952.
9. Zhang Y.E., Wang J.N., Tang J.M., et al. In vivo protein transduction: delivery of PEP-1-SOD1 fusion protein into myocardium efficiently protects against ischemic insult. Mol Cells 2009, 27:159-166.
10. Idris A.H., Becker L.B., Ornato J.P., et al. Utstein-style guidelines for uniform reporting of laboratory CPR research. Resuscitation 1996, 33:69-84.
11. McCord J.M., Fridovich I. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J Biol Chem 1969, 244:6049-6055.
12. Hendrickx H.H., Rao G.R., Safar P., Gisvold S.E. Asphyxia, cardiac arrest and resuscitation in rats. I. Short term recovery. Resuscitation 1984, 12:97-116.
13. Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979, 95:351-358.
14. Wang J.N., Ding P., Huang Y.Z., et al. The protective effect of PEP-1-SOD1 preconditioning on hypoxia/reoxygenation injury in cultured human umbilical vein endothelial cells. Zhonghua Xin Xue Guan Bing Za Zhi 2007, 35:750-756.
15. Cerchiari E.L., Hoel T.M., Safar P., Sclabassi R.J. Protective effects of combined superoxide dismutase and deferoxamine on recovery of cerebral blood flow and function after cardiac arrest in dogs. Stroke 1987, 18:869-878.
16. White B.C., Sullivan J.M., DeGracia D.J., et al. Brain ischemia and reperfusion: molecular mechanisms of neuronal injury. J Neurol Sci 2000, 179:1-33.
17. Schäfer B.W., Heizmann C.W. The S100 family of EF-hand calcium-binding proteins: functions and pathology. Trends Biochem Sci 1996, 21:134-140.
18. Tanaka Y., Marumo T., Omura T., Yoshida S. Early increases in serum S100B are associated with cerebral hemorrhage in a rat model of focal cerebral ischemia. Brain Res 2008, 1227:248-254.
19. Rundgren M., Karlsson T., Nielsen N., et al. Neuron specific enolase and S-100B as predictors of outcome after cardiac arrest and induced hypothermia. Resuscitation 2009, 80:784-789.
20. Roine R.O., Somer H., Kaste M., Viinikka L., Karonen S.L. Neurological outcome after out-of-hospital cardiac arrest. Prediction by cerebrospinal fluid enzyme analysis. Arch Neurol 1989, 46:753-756.
21. Cunningham R.T., Young I.S., Winder J., et al. Serum neurone specific enolase (NSE) levels as an indicator of neuronal damage in patients with cerebral infarction. Eur J Clin Invest 1991, 21:497-500.
22. Shinozaki K., Oda S., Sadahiro T., et al. S-100B and neuron-specific enolase as predictors of neurological outcome in patients after cardiac arrest and return of spontaneous circulation: a systematic review. Crit Care 2009, 13:R121.
23. Rea T.D., Eisenberg M.S., Becker L.J., Murray J.A., Hearne T. Temporal trends in sudden cardiac arrest: a 25-year emergency medical services perspective. Circulation 2003, 107:2780-2785.
24. Goss J.R., Taffe K.M., Kochanek P.M., DeKosky S.T. The antioxidant enzymes glutathione peroxidase and catalase increase following traumatic brain injury in the rat. Exp Neurol 1997, 146:291-294.
25. Gönenc S., Acikgöz O., Kayatekin B.M., Uysal N., Akhisaroglu M. Effects of footshock stress on superoxide dismutase and glutathione peroxidase enzyme activities and thiobarbituric acid reactive substances levels in the rat prefrontal cortex and striatum. Neurosci Lett 2000, 289:107-110.
26. Szeto H.H. Mitochondria-targeted peptide antioxidants: novel neuroprotective agents. AAPS J 2006, 8:E521-E531.
27. Yasui K., Baba A. Therapeutic potential of superoxide dismutase (SOD) for resolution of inflammation. Inflamm Res 2006, 55:359-363.
28. Tréhin R., Merkle H.P. Chances and pitfalls of cell penetrating peptides for cellular drug delivery. Eur J Pharm Biopharm 2004, 58:209-223.
29. Kofler J., Hurn P.D., Traystman R.J. SOD1 overexpression and female sex exhibit region-specific neuroprotection after global cerebral ischemia due to cardiac arrest. J Cereb Blood Flow Metab 2005, 25:1130-1137.
30. Davis A.S., Zhao H., Sun G.H., Sapolsky R.M., Steinberg G.K. Gene therapy using SOD1 protects striatal neurons from experimental stroke. Neurosci Lett 2007, 411:32-36.
31. Taylor J.E., Fernandez-Patron C. Delivery of bioactive, gel-isolated proteins into live cells. Electrophoresis 2003, 24:1331-1337.
32. Zhu W.L., Lan H., Park I.S., et al. Design and mechanism of action of a novel bacteria-selective antimicrobial peptide from the cell-penetrating peptide Pep-1. Biochem Biophys Res Commun 2006, 349:769-774.
33. Park N., Yamanaka K., Tran D., et al. The cell-penetrating peptide. Pep-1, has activity against intracellular chlamydial growth but not extracellular forms of Chlamydia trachomatis. J Antimicrob Chemother 2009, 63:115-123.